• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗的帕金森病患者新冠死亡率可能更高。

Parkinson's disease patients may have higher rates of Covid-19 mortality in Iran.

机构信息

Functional Neurosurgery Research Center, Shohada-e Tajrish Comprehensive Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Department of Functional Neurosurgery, Medical School, Isfahan University of Medical Sciences, Isfahan, Iran.

出版信息

Parkinsonism Relat Disord. 2021 Aug;89:90-92. doi: 10.1016/j.parkreldis.2021.07.002. Epub 2021 Jul 8.

DOI:10.1016/j.parkreldis.2021.07.002
PMID:34256334
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8264275/
Abstract

BACKGROUND

Parkinson's disease (PD) patients may be at increased risk of Covid-19 mortality due to the nature of their disease or underlying conditions.

METHOD

The information of 12,909 Covid-19 patients who were hospitalized during the last eleven months were collected from the data depository of two referral university hospitals. Eighty-seven of these patients were diagnosed with PD, and thirty-one of these PD patients died because of Covid-19. 2132 other deaths occurred in these centers, related to Covid-19 of non-PD patients. Fisher exact test, Chi-square test, and Principle component analysis were used for statistical analysis.

RESULTS

The mortality among PD patients and other hospitalized patients was 35.6% and 19.8%, respectively, and the difference between the mortality of these two groups was found to be statistically significant (p-value<0.01). The mean age of PD patients who passed away was 77.06 ± 7.46, and it was not significantly different from that of alive PD patients (p-value>0.05). Alzheimer's disease as an underlying condition was more frequent in deceased PD patients in comparison to survived PD patients, and this difference was found to be statistically significant (p-value<0.01).

CONCLUSION

PD patients possess a higher rate of Covid-19 mortality in comparison with other patients hospitalized for Covid-19. PD pathophysiology, advanced age, underlying conditions, and health systems' efficacy may play an essential role in such an outcome.

摘要

背景

由于疾病本身或潜在疾病的性质,帕金森病(PD)患者感染新冠病毒后死亡的风险可能会增加。

方法

从两家转诊大学医院的数据存储库中收集了 12909 名在过去十一个月内因新冠病毒住院的患者的信息。其中 87 名患者被诊断为 PD,31 名 PD 患者因新冠病毒死亡。在这些中心还发生了 2132 例与非 PD 患者的新冠病毒相关的其他死亡。使用 Fisher 确切检验、卡方检验和主成分分析进行统计分析。

结果

PD 患者和其他住院患者的死亡率分别为 35.6%和 19.8%,两组死亡率之间的差异具有统计学意义(p 值<0.01)。去世的 PD 患者的平均年龄为 77.06±7.46,与存活的 PD 患者的平均年龄无显著差异(p 值>0.05)。与存活的 PD 患者相比,患有阿尔茨海默病等潜在疾病的 PD 患者在死亡患者中更为常见,这种差异具有统计学意义(p 值<0.01)。

结论

与因新冠病毒住院的其他患者相比,PD 患者的新冠病毒死亡率更高。PD 的病理生理学、高龄、潜在疾病和卫生系统的效能可能在这种结果中起重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efdc/8264275/c3f6222c41de/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efdc/8264275/c3f6222c41de/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efdc/8264275/c3f6222c41de/gr1_lrg.jpg

相似文献

1
Parkinson's disease patients may have higher rates of Covid-19 mortality in Iran.伊朗的帕金森病患者新冠死亡率可能更高。
Parkinsonism Relat Disord. 2021 Aug;89:90-92. doi: 10.1016/j.parkreldis.2021.07.002. Epub 2021 Jul 8.
2
Predictors of COVID-19 outcome in Parkinson's disease.帕金森病患者 COVID-19 结局的预测因素。
Parkinsonism Relat Disord. 2020 Sep;78:134-137. doi: 10.1016/j.parkreldis.2020.08.012. Epub 2020 Aug 13.
3
Dementia and Parkinson's Disease: Risk Factors for 30-Day Mortality in Nursing Home Residents with COVID-19.痴呆和帕金森病:COVID-19 养老院居民 30 天死亡率的危险因素。
J Alzheimers Dis. 2021;84(3):1173-1181. doi: 10.3233/JAD-210319.
4
Risk of Hospitalization and Death for COVID-19 in People with Parkinson's Disease or Parkinsonism.帕金森病或帕金森综合征患者感染 COVID-19 的住院和死亡风险。
Mov Disord. 2021 Jan;36(1):1-10. doi: 10.1002/mds.28408. Epub 2020 Dec 2.
5
Characteristic of Parkinson's disease with severe COVID-19: a study of 10 cases from Wuhan.伴有严重 COVID-19 的帕金森病特征:来自武汉的 10 例研究。
J Neural Transm (Vienna). 2021 Jan;128(1):37-48. doi: 10.1007/s00702-020-02283-y. Epub 2021 Jan 3.
6
Dementia is an age-independent risk factor for severity and death in COVID-19 inpatients.痴呆症是 COVID-19 住院患者严重程度和死亡的与年龄无关的风险因素。
Alzheimers Dement. 2021 Nov;17(11):1818-1831. doi: 10.1002/alz.12352. Epub 2021 Apr 21.
7
Parkinson's disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A systematic review, meta-analysis, and meta-regression.帕金森病可能会使住院患者的2019冠状病毒病(COVID-19)肺炎预后恶化:一项系统评价、荟萃分析和荟萃回归分析。
Parkinsonism Relat Disord. 2021 Jun;87:155-161. doi: 10.1016/j.parkreldis.2021.04.019. Epub 2021 Apr 24.
8
Clinical Profiles and Mortality of COVID-19 Inpatients with Parkinson's Disease in Germany.德国 COVID-19 住院帕金森病患者的临床特征和死亡率。
Mov Disord. 2021 May;36(5):1049-1057. doi: 10.1002/mds.28586. Epub 2021 May 4.
9
The effects of Alzheimer's and Parkinson's disease on 28-day mortality of COVID-19.阿尔茨海默病和帕金森病对 COVID-19 28 天死亡率的影响。
Rev Neurol (Paris). 2022 Jan-Feb;178(1-2):129-136. doi: 10.1016/j.neurol.2021.08.002. Epub 2021 Sep 13.
10
The impact of SARS-COV2 infection on people in residential care with Parkinson Disease or parkinsonisms: Clinical case series study.严重急性呼吸综合征冠状病毒2(SARS-CoV2)感染对患有帕金森病或帕金森综合征的机构照护人群的影响:临床病例系列研究
PLoS One. 2021 May 6;16(5):e0251313. doi: 10.1371/journal.pone.0251313. eCollection 2021.

引用本文的文献

1
Cerebral blood flow alterations and host genetic association in individuals with long COVID: A transcriptomic-neuroimaging study.长新冠患者的脑血流改变与宿主基因关联:一项转录组学-神经影像学研究。
J Cereb Blood Flow Metab. 2025 Mar;45(3):431-442. doi: 10.1177/0271678X241277621. Epub 2024 Aug 23.
2
COVID-19 and Parkinson's disease: a single-center study and Mendelian randomization study.2019冠状病毒病与帕金森病:一项单中心研究及孟德尔随机化研究
Sci Rep. 2024 Jul 17;14(1):16517. doi: 10.1038/s41598-024-66197-5.
3
No genetic link between Parkinson's disease and SARS-CoV-2 infection: a two-sample Mendelian randomization study.

本文引用的文献

1
Outcome of Hospitalized Parkinson's Disease Patients with and without COVID-19.患与未患新型冠状病毒肺炎的住院帕金森病患者的结局
Mov Disord Clin Pract. 2021 May 3;8(6):859-867. doi: 10.1002/mdc3.13231. eCollection 2021 Aug.
2
Clinical Profiles and Mortality of COVID-19 Inpatients with Parkinson's Disease in Germany.德国 COVID-19 住院帕金森病患者的临床特征和死亡率。
Mov Disord. 2021 May;36(5):1049-1057. doi: 10.1002/mds.28586. Epub 2021 May 4.
3
Prevalence and impact of COVID-19 in Parkinson's disease: evidence from a multi-center survey in Tuscany region.
帕金森病与新型冠状病毒感染之间不存在遗传联系:一项两样本孟德尔随机化研究。
Front Neurol. 2024 Jun 28;15:1393888. doi: 10.3389/fneur.2024.1393888. eCollection 2024.
4
Movement Disorders and SARS-CoV-2.运动障碍与严重急性呼吸综合征冠状病毒2
Mov Disord Clin Pract. 2022 Dec 7;10(Suppl 2):S9-S17. doi: 10.1002/mdc3.13615. eCollection 2023 Aug.
5
Characteristics and outcomes of elderly patients with Parkinson's disease hospitalized due to COVID‑19‑associated pneumonia.因新型冠状病毒肺炎相关肺炎住院的老年帕金森病患者的特征及结局
Med Int (Lond). 2023 Jul 4;3(4):34. doi: 10.3892/mi.2023.94. eCollection 2023 Jul-Aug.
6
Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital.帕金森病患者中 COVID-19 的患病率和结局:急症环境和医院。
Int Rev Neurobiol. 2022;165:35-62. doi: 10.1016/bs.irn.2022.03.001. Epub 2022 Apr 20.
7
COVID-19 outcomes in hospitalized Parkinson's disease patients in two pandemic waves in 2020: a nationwide cross-sectional study from Germany.2020年两波疫情期间德国住院帕金森病患者的新冠病毒病结局:一项全国性横断面研究
Neurol Res Pract. 2022 Jul 11;4(1):27. doi: 10.1186/s42466-022-00192-x.
8
Movement Disorders Associated with COVID-19.与新型冠状病毒肺炎相关的运动障碍
Parkinsons Dis. 2021 Nov 8;2021:3227753. doi: 10.1155/2021/3227753. eCollection 2021.
9
Parkinson's disease and COVID-19: a systematic review and meta-analysis.帕金森病与 COVID-19:系统评价和荟萃分析。
Neurol Sci. 2022 Feb;43(2):775-783. doi: 10.1007/s10072-021-05756-4. Epub 2021 Nov 17.
COVID-19 在帕金森病中的流行情况和影响:来自托斯卡纳地区多中心调查的证据。
J Neurol. 2021 Apr;268(4):1179-1187. doi: 10.1007/s00415-020-10002-6. Epub 2020 Sep 3.
4
Predictors of COVID-19 outcome in Parkinson's disease.帕金森病患者 COVID-19 结局的预测因素。
Parkinsonism Relat Disord. 2020 Sep;78:134-137. doi: 10.1016/j.parkreldis.2020.08.012. Epub 2020 Aug 13.
5
COVID-19 in Parkinson's Disease Patients Living in Lombardy, Italy.意大利伦巴第地区帕金森病患者的 COVID-19 状况。
Mov Disord. 2020 Jul;35(7):1089-1093. doi: 10.1002/mds.28176. Epub 2020 Jun 26.
6
COVID-19: An Early Review of Its Global Impact and Considerations for Parkinson's Disease Patient Care.新型冠状病毒肺炎:对其全球影响及帕金森病患者护理考量的早期综述
J Mov Disord. 2020 May;13(2):105-114. doi: 10.14802/jmd.20042. Epub 2020 Apr 30.
7
Impact of the COVID-19 Pandemic on Parkinson's Disease and Movement Disorders.2019年冠状病毒病大流行对帕金森病和运动障碍的影响
Mov Disord. 2020 May;35(5):711-715. doi: 10.1002/mds.28067. Epub 2020 Apr 16.
8
Mortality in Parkinson's disease: a systematic review and meta-analysis.帕金森病的死亡率:一项系统评价与荟萃分析
Mov Disord. 2014 Nov;29(13):1615-22. doi: 10.1002/mds.25898. Epub 2014 May 13.